|
Canada-0-LaboratoriesTesting 公司名錄
|
公司新聞:
- Home | Discover Oncology | Springer Nature Link
Discover Oncology is an open access journal publishing content that interfaces at all levels of cancer research Indexed in DOAJ, SCIE, PubMedCentral and Scopus with a CiteScore 2024 of 1 9 Covers basic and translational science, through to preclinical, clinical, and epidemiology Formerly published as Hormones and Cancer A journal in Springer Nature’s Discover Series: Rigorous
- Aims and scope | Discover Oncology | Springer Nature Link
Aims and scope Discover Oncology is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a high level of author service at every stage Discover Oncology is a fully open access general oncology journal that aims to provide a unified forum for researchers and clinicians
- Submission guidelines | Discover Oncology | Springer Nature Link
Introduction By following the guidelines below, your submission is more likely to pass through all of the quality checks we perform You will avoid the most
- Welcome from the new Discover Oncology journal | Discover Oncology . . .
The field of oncology has seen significant growth in research, necessitating a dedicated platform for comprehensive discussion and dissemination of findings Discover Oncology aims to fill this gap by providing an open-access journal that encompasses all aspects of cancer research, facilitating efficient publication processes and supporting both established and early-career researchers
- Multi-omics strategies for biomarker discovery and . . . - Springer
Multi-omics strategies, integrating genomics, transcriptomics, proteomics, and metabolomics, have revolutionized biomarker discovery and enabled novel applications in personalized oncology Despite rapid technological developments, a comprehensive synthesis addressing integration strategies, analytical workflows, and translational applications has been lacking This review presents a
- AI-driven biomarker discovery: enhancing precision in cancer . . . - Springer
In oncology, the use of artificial intelligence (AI) represents a transformative advancement in cancer diagnosis, prognosis, and treatment The use of AI in biomarker discovery improves precision medicine by uncovering biomarker signatures that are essential for early detection and treatment of diseases within vast and diverse datasets
- Home | Journal of Neuro-Oncology | Springer Nature Link
Journal of Neuro-Oncology Discovery – open for submissions Journal of Neuro-Oncology Discovery is a full Open Access, inclusive-science journal inviting authors to submit manuscripts covering basic, translational, clinical and interdisciplinary research in neuro-oncology
- Advances in Oncology: Biomarker Discovery and Drug Target Innovation
Research in oncology has undergone a transformative evolution propelled by advances in biomarker discovery and drug target innovation Biomarkers that encompass a wide range of biological molecules are essential in the early detection, diagnosis and prognosis of cancer
- Meet the Editor-in-Chief for Discover Oncology - Springer
Meet the Editor-in-Chief for Discover Oncology Professor Eleonora Candi, Editor-in-Chief “Discover Oncology, being a broad-scope cancer research and oncology journal, will meet the needs of the scientific community in this growing field
- Journal of Neuro-Oncology Discovery - Springer
The Journal of Neuro-Oncology Discovery is a peer-reviewed, open access journal committed to advancing innovation across all domains of neuro-oncology, from fundamental laboratory insights and translational breakthroughs to clinical practice and multidisciplinary collaborations We prioritize scientific rigor and sound methodology above perceived novelty or impact, ensuring that all
|
|